Central Venous Pressure and Right Atrial Pressure Measurements in Supine, Semi-recumbent and Trendelenburg Position
1 other identifier
observational
16
1 country
1
Brief Summary
Intensive care is directed towards patients with severe illness or risk of serious outcomes following, for example, surgery. Central venous pressure (CVP) is an important part of the hemodynamic assessment of patients in surgery and the intensive care unit (ICU). CVP is normally measured via a central venous catheter (CVC) inserted through the subclavian or internal jugular vein, with the tip placed at the junction to the right atrium. A pressure tubing is connected to one of the branches of the CVC and then connected to a pressure sensor that sends a digital signal to the monitoring screen where CVP can be read in mmHg. To accurately read CVP, the pressure sensor must be positioned at the level of the right atrium. Different external reference points are used nationally and internationally to locate the correct height for the pressure sensor. This study aims to investigate the most commonly used external reference points for CVP measurement in various body positions compared to CVP measured via a solid state pressure catheter in the right atrium (RAP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2023
CompletedFirst Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
November 26, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedMay 20, 2025
May 1, 2025
1.1 years
April 30, 2024
May 14, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Difference in mmHg between Right atrial pressure (RAP) and Central venous pressure (CVP) in supine position
Difference in mmHg between RAP (Millar Micro-Cath) and CVP.
3 minutes after body position change
Difference in mmHg between RAP and CVP in semi-recumbent position
Difference in mmHg between RAP (Millar Micro-Cath) and CVP.
3 minutes after body position change
Difference in mmHg between RAP and CVP in Trendelenburg position
Difference in mmHg between RAP (Millar Micro-Cath) and CVP.
3 minutes after body position change
Difference in mmHg between RAP and CVP in right lateral position
Difference in mmHg between RAP (Millar Micro-Cath) and CVP.
3 minutes after body position change
Difference in mmHg between RAP and CVP in left lateral position
Difference in mmHg between RAP (Millar Micro-Cath) and CVP.
3 minutes after body position change
Secondary Outcomes (10)
Change in hemodynamic parameters after body position change
3 minutes after body position change
Change in hemodynamic parameters after PEEP change
1 minutes after PEEP change
Change in hemodynamic parameters after body position change
3 minutes after body position change
Change in hemodynamic parameters after body position change
3 minutes after body position change
Change in hemodynamic parameters after body position change
3 minutes after body position change
- +5 more secondary outcomes
Eligibility Criteria
Critically ill patients, in mechanical ventilation, sedated to RASS -4 or -5 in mechanical ventilation with a 4 or 5 line CVC.
You may qualify if:
- Critically ill patients in mechanical ventilation with an arterial line and a four or five lumen CVC.
You may not qualify if:
- under 18 years of age
- in a dynamic phase of their illness i.e. ongoing treatment of severe circulatory or respiratory failure
- positive end-expiratory pressure (PEEP) \>14 cmH20 or intolerance to change of body position.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sahlgrenska University Hospital
Gothenburg, Västra Götaland County, 41345, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lotta Johansson, MD
Sahlgrenska University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD student
Study Record Dates
First Submitted
April 30, 2024
First Posted
November 26, 2024
Study Start
November 15, 2023
Primary Completion
December 15, 2024
Study Completion
December 30, 2024
Last Updated
May 20, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
All excel data that underlie results in publication